NEUROFIBROMATOSIS
Clinical trials for NEUROFIBROMATOSIS explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer drug shrink painful NF1 skin tumors? early trial launches
Disease control Recruiting nowThis early study tests if a drug called IMLYGIC, already used for some skin cancers, can safely treat bothersome skin tumors in adults with NF1. Ten participants will receive injections directly into their tumors over four cycles. The goal is to see if the treatment is feasible a…
Matched conditions: NEUROFIBROMATOSIS
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Russian NF1 Patients' health under the microscope: no treatment, just facts
Knowledge-focused Recruiting nowThis study aims to collect information about 200 adults in Russia who have neurofibromatosis type 1 (NF1) and related tumors called plexiform neurofibromas. Researchers will look at patients' medical records and interview them to understand their age, symptoms, and overall health…
Matched conditions: NEUROFIBROMATOSIS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 17, 2026 01:34 UTC
-
NF2 patients needed for Decade-Long observation study
Knowledge-focused Recruiting nowThis study follows 269 people aged 8 to 75 with neurofibromatosis type 2 (NF2) for up to 10 years. Researchers will track tumor growth, hearing, speech, and swallowing through yearly MRIs, hearing tests, and exams. The goal is to better understand how NF2 progresses, not to test …
Matched conditions: NEUROFIBROMATOSIS
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC